4FG
ABBV icon

4Thought Financial Group’s AbbVie ABBV Stock Holding History

4Thought Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-218
Closed -$33.8K – 109
2023
Q4 		$33.8K Buy
+218
New +$31.8K 0.02% 65
2022
Q3 		– Sell
-218
Closed -$33K – 92
2022
Q2 		$33K Hold
218
– – 0.03% 62
2022
Q1 		$35K Hold
218
– – 0.03% 59
2021
Q4 		$30K Hold
218
– – 0.02% 61
2021
Q3 		$24K Hold
218
– – 0.02% 68
2021
Q2 		$25K Buy
+218
New +$24.6K 0.02% 68

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

4Thought Financial Group's ABBV Position: Q1 2024 in Review

4Thought Financial Group sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 218 shares — an estimated $33.8K sold.

4Thought Financial Group first reported a position in ABBV in Q2 2021 and held it in 6 quarters. The position peaked at $35K in Q1 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • 4Thought Financial Group reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • 4Thought Financial Group sold 218 AbbVie shares in Q1 2024, an estimated $33.8K.
  • 4Thought Financial Group first reported a position in AbbVie in Q2 2021 and held it in 6 quarters.
  • 4Thought Financial Group's AbbVie position peaked at $35K in Q1 2022.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on 4Thought Financial Group's 13F filing for Q1 2024, filed 24 Apr 2024.